Homelessness Diversion for Emergency Department Patients Facing Homelessness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a program designed to help people avoid homelessness can reduce emergency room visits. It seeks to identify who benefits most from this program and how it can be improved for different communities. Participants will either receive the usual treatment (treatment-as-usual, TAU) or join the new homelessness diversion program. Suitable candidates for this trial are those at imminent risk of becoming homeless, who speak English or Spanish, have recently been discharged from specific hospitals, and have Medicaid, Medicare, or no insurance. As an unphased trial, this study provides a unique opportunity to contribute to innovative solutions for preventing homelessness.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this homelessness diversion program is safe?
Research has shown that programs like the one under study, which help people avoid entering homeless shelters, are generally safe. These programs aim to find alternative housing solutions by offering resources and support, not medical treatment.
No evidence suggests negative effects from this type of program. The goal is to reduce emergency room visits and help people find stable housing. Participants in similar programs have not reported any harm to their health. Instead, these programs aim to improve overall well-being by addressing housing issues.
Since this is not a drug or medical treatment, the focus remains on providing support and resources, which participants manage well.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to support emergency department patients facing homelessness. Unlike the standard treatment-as-usual, which may focus on immediate medical needs, the homelessness diversion (HD) approach aims to address housing stability directly, potentially preventing future homelessness. This strategy could lead to more long-term solutions, reducing the cycle of repeated hospital visits. By focusing on immediate intervention and connecting patients with housing resources, this method might offer a more holistic solution to a complex problem.
What evidence suggests that this trial's treatments could be effective for reducing emergency department use among patients facing homelessness?
This trial will compare the effectiveness of two approaches for patients facing homelessness: the Homeless Diversion (HD) program and Treatment-as-Usual (TAU). Research has shown that programs designed to prevent homelessness, like the HD program in this trial, can effectively reduce the number of people without homes and help them find stable housing. Studies indicate that these programs are especially effective when implemented in hospital emergency rooms, as they address the social issues affecting both health and housing. These programs rank among the most effective ways to assist people experiencing homelessness in the community. By directly tackling housing instability, these programs can also improve overall health. This method may succeed more than traditional ways of dealing with homelessness.678910
Who Is on the Research Team?
Jack Tsai, PhD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for English or Spanish speakers discharged from a Harris Health Hospital ED who are at imminent risk of homelessness and have Medicaid, Medicare, or no insurance. It's not for those with a legal guardian or plans to leave Texas within 6 months.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive homelessness diversion services integrated into the emergency department
Follow-up
Participants are monitored for changes in health-related quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Homeless diversion (HD)
- Treatment-as-usual (TAU)
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator